News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
237,077 Results
Type
Article (17604)
Company Profile (16)
Press Release (219457)
Multimedia
Podcasts (25)
Webinars (5)
Section
Business (61957)
Career Advice (266)
Deals (10154)
Drug Delivery (37)
Drug Development (29448)
Employer Resources (33)
FDA (5847)
Job Trends (4851)
News (108350)
Policy (9813)
Tag
Academia (1842)
Accelerated approval (7)
Adcomms (12)
Allergies (49)
Alliances (17092)
ALS (71)
Alzheimer's disease (726)
Antibody-drug conjugate (ADC) (110)
Approvals (6072)
Artificial intelligence (166)
Autoimmune disease (37)
Automation (12)
Bankruptcy (65)
Best Places to Work (4141)
BIOSECURE Act (17)
Biosimilars (60)
Biotechnology (14)
Bladder cancer (88)
Brain cancer (29)
Breast cancer (304)
Cancer (2202)
Cardiovascular disease (180)
Career advice (248)
Career pathing (4)
CAR-T (125)
CDC (6)
Cell therapy (285)
Cervical cancer (19)
Clinical research (25214)
Collaboration (560)
Compensation (81)
Complete response letters (11)
COVID-19 (1252)
CRISPR (39)
C-suite (293)
Cystic fibrosis (44)
Data (2536)
Denatured (2)
Depression (59)
Diabetes (141)
Diagnostics (2382)
Digital health (12)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (85)
Drug pricing (66)
Drug shortages (2)
Duchenne muscular dystrophy (68)
Earnings (19351)
Editorial (22)
Employer branding (4)
Employer resources (29)
Events (37046)
Executive appointments (334)
FDA (7053)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (671)
Gene editing (61)
Generative AI (6)
Gene therapy (203)
GLP-1 (210)
Government (1613)
Grass and pollen (3)
Guidances (127)
Healthcare (7063)
HIV (22)
Huntington's disease (5)
IgA nephropathy (19)
Immunology and inflammation (64)
Immuno-oncology (17)
Indications (41)
Infectious disease (1349)
Inflammatory bowel disease (85)
Inflation Reduction Act (4)
Influenza (36)
Intellectual property (68)
Interviews (25)
IPO (5037)
IRA (25)
Job creations (880)
Job search strategy (231)
JPM (54)
Kidney cancer (11)
Labor market (26)
Layoffs (107)
Leadership (3)
Legal (2050)
Liver cancer (38)
Longevity (6)
Lung cancer (294)
Lymphoma (205)
Machine learning (15)
Management (10)
Manufacturing (218)
MASH (42)
Medical device (4178)
Medtech (4188)
Mergers & acquisitions (5532)
Metabolic disorders (302)
Multiple sclerosis (52)
NASH (6)
Neurodegenerative disease (124)
Neuropsychiatric disorders (31)
Neuroscience (1245)
Neurotech (1)
NextGen: Class of 2026 (2208)
Non-profit (2252)
Now hiring (6)
Obesity (120)
Opinion (78)
Ovarian cancer (92)
Pain (66)
Pancreatic cancer (98)
Parkinson's disease (148)
Partnered (12)
Patents (131)
Patient recruitment (166)
Peanut (23)
People (23459)
Pharmaceutical (6)
Pharmacy benefit managers (6)
Phase 1 (7450)
Phase 2 (10807)
Phase 3 (8812)
Pipeline (1877)
Policy (108)
Postmarket research (1070)
Preclinical (3103)
Press Release (58)
Prostate cancer (103)
Psychedelics (23)
Radiopharmaceuticals (86)
Rare diseases (266)
Real estate (1716)
Recruiting (13)
Regulatory (7716)
Reports (13)
Research institute (2021)
Resumes & cover letters (23)
Rett syndrome (8)
RNA editing (5)
RSV (20)
Schizophrenia (64)
Series A (95)
Series B (61)
Sickle cell disease (39)
Special edition (6)
Spinal muscular atrophy (62)
Sponsored (11)
Startups (1348)
Stomach cancer (4)
Supply chain (30)
Tariffs (28)
The Weekly (23)
Vaccines (402)
Venture capital (41)
Weight loss (53)
Women's health (25)
Worklife (3)
Date
Last 7 days (198)
Last 30 days (662)
Last 365 days (10057)
2026 (1337)
2025 (10213)
2024 (11744)
2023 (13764)
2022 (16905)
2021 (19127)
2020 (18497)
2019 (16342)
2018 (12297)
2017 (11358)
2016 (11426)
2015 (13613)
2014 (10185)
2013 (8158)
2012 (8729)
2011 (8995)
2010 (7894)
Location
Africa (250)
Alabama (59)
Alaska (3)
Arizona (91)
Arkansas (4)
Asia (13261)
Australia (2564)
California (3064)
Canada (962)
China (334)
Colorado (136)
Connecticut (142)
Delaware (172)
Europe (28281)
Florida (569)
Georgia (114)
Hawaii (1)
Idaho (19)
Illinois (275)
India (25)
Indiana (155)
Iowa (8)
Japan (221)
Kansas (71)
Kentucky (17)
Louisiana (6)
Maine (12)
Maryland (429)
Massachusetts (2199)
Michigan (57)
Minnesota (182)
Mississippi (1)
Missouri (49)
Montana (8)
Nebraska (7)
Nevada (34)
New Hampshire (26)
New Jersey (2955)
New Mexico (8)
New York (968)
North Carolina (372)
North Dakota (4)
Northern California (1560)
Ohio (106)
Oklahoma (9)
Oregon (10)
Pennsylvania (656)
Puerto Rico (8)
Rhode Island (13)
South America (347)
South Carolina (14)
Southern California (1103)
Tennessee (63)
Texas (605)
United States (13812)
Utah (106)
Vermont (1)
Virginia (66)
Washington D.C. (42)
Washington State (337)
West Virginia (2)
Wisconsin (31)
237,077 Results for "j craig venter institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’
Reporting Q4 and full year earnings on Wednesday, J&J executives hailed growth across the healthcare giant’s portfolio while standing fast on its talc lawsuit and tariffs.
January 21, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
November 18, 2025
·
3 min read
Press Releases
Adm. Craig Faller (Ret.) and Adele Gulfo Elected to Battelle Board of Directors
November 20, 2025
·
3 min read
Press Releases
Northwell’s Feinstein Institutes’ Kevin J. Tracey named to TIME100 2026 Health list
February 12, 2026
·
4 min read
Immunology and inflammation
J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark
J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action could improve on existing therapies.
January 5, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
November 13, 2025
·
1 min read
Press Releases
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
November 12, 2025
·
3 min read
Press Releases
Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer
September 18, 2025
·
7 min read
Artificial intelligence
J&J, Lilly Crest AI Wave With Nvidia Partnerships
Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to create the industry’s ‘most powerful supercomputer’ and J&J building a virtual operating room.
October 29, 2025
·
2 min read
·
Tristan Manalac
Biotech Bay
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
Cerus Corporation (Nasdaq: CERS) announced today that Kevin Green, Cerus’ chief financial officer, is scheduled to participate at the 21st Annual Craig-Hallum Institution Investor Conference in Minneapolis, on Wednesday, May 29th.
May 22, 2024
·
1 min read
1 of 23,708
Next
